Quince Therapeutics files 8-K on director changes
Quince Therapeutics said several directors resigned from its board and named four new directors effective Oct. 8, 2026. The filing also disclosed compensation terms for Keith R. Fandrick.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.